Global CMO Peptide Market Research Report 2025

Publication ID:

PB502253629

Publication Date:

February 13, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for CMO Peptide was valued at US$ 3601 million in the year 2024 and is projected to reach a revised size of US$ 9425 million by 2031, growing at a CAGR of 15.0% during the forecast period.
Peptides are synthesized by coupling the carboxyl group of one amino acid to the amino group of another amino acid molecule. Due to the possibility of unintended reactions, protecting groups are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.
The customized peptide synthesis market is driven by the growing demand for peptides in various fields, including pharmaceuticals, biotechnology, and research. Customized peptides are essential tools for drug development, therapeutic applications, and biochemical research. The increasing focus on personalized medicine and targeted therapies further propels market growth. Moreover, advancements in peptide synthesis technologies and the availability of automated synthesis platforms have improved the efficiency and scalability of customized peptide production. However, challenges include the complexity of synthesizing certain peptides, the need for stringent quality control measures, and the cost associated with custom synthesis services. Addressing these challenges through continuous research and development, process optimization, and competitive pricing will be crucial for sustaining the growth of the customized peptide synthesis market.
This report aims to provide a comprehensive presentation of the global market for CMO Peptide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CMO Peptide.
The CMO Peptide market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CMO Peptide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CMO Peptide companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bachem
PolyPeptide
USV Peptides
Thermofischer
Bio Basic
JPT
Genscript
Xinbang Pharma
ScinoPharm
AmbioPharm
SN Biopharm
CBL
Piramal Pharma
CordenPharma
CPC Scientific
Segment by Type
APIs and Intermediates
FDF
Segment by Application
Commercial
Academic Research
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CMO Peptide company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CMO Peptide Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 APIs and Intermediates
1.2.3 FDF
1.3 Market by Application
1.3.1 Global CMO Peptide Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Commercial
1.3.3 Academic Research
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CMO Peptide Market Perspective (2020-2031)
2.2 Global CMO Peptide Growth Trends by Region
2.2.1 Global CMO Peptide Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CMO Peptide Historic Market Size by Region (2020-2025)
2.2.3 CMO Peptide Forecasted Market Size by Region (2026-2031)
2.3 CMO Peptide Market Dynamics
2.3.1 CMO Peptide Industry Trends
2.3.2 CMO Peptide Market Drivers
2.3.3 CMO Peptide Market Challenges
2.3.4 CMO Peptide Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CMO Peptide Players by Revenue
3.1.1 Global Top CMO Peptide Players by Revenue (2020-2025)
3.1.2 Global CMO Peptide Revenue Market Share by Players (2020-2025)
3.2 Global CMO Peptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CMO Peptide Revenue
3.4 Global CMO Peptide Market Concentration Ratio
3.4.1 Global CMO Peptide Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CMO Peptide Revenue in 2024
3.5 Global Key Players of CMO Peptide Head office and Area Served
3.6 Global Key Players of CMO Peptide, Product and Application
3.7 Global Key Players of CMO Peptide, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CMO Peptide Breakdown Data by Type
4.1 Global CMO Peptide Historic Market Size by Type (2020-2025)
4.2 Global CMO Peptide Forecasted Market Size by Type (2026-2031)
5 CMO Peptide Breakdown Data by Application
5.1 Global CMO Peptide Historic Market Size by Application (2020-2025)
5.2 Global CMO Peptide Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CMO Peptide Market Size (2020-2031)
6.2 North America CMO Peptide Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CMO Peptide Market Size by Country (2020-2025)
6.4 North America CMO Peptide Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CMO Peptide Market Size (2020-2031)
7.2 Europe CMO Peptide Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CMO Peptide Market Size by Country (2020-2025)
7.4 Europe CMO Peptide Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CMO Peptide Market Size (2020-2031)
8.2 Asia-Pacific CMO Peptide Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CMO Peptide Market Size by Region (2020-2025)
8.4 Asia-Pacific CMO Peptide Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CMO Peptide Market Size (2020-2031)
9.2 Latin America CMO Peptide Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CMO Peptide Market Size by Country (2020-2025)
9.4 Latin America CMO Peptide Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CMO Peptide Market Size (2020-2031)
10.2 Middle East & Africa CMO Peptide Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CMO Peptide Market Size by Country (2020-2025)
10.4 Middle East & Africa CMO Peptide Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bachem
11.1.1 Bachem Company Details
11.1.2 Bachem Business Overview
11.1.3 Bachem CMO Peptide Introduction
11.1.4 Bachem Revenue in CMO Peptide Business (2020-2025)
11.1.5 Bachem Recent Development
11.2 PolyPeptide
11.2.1 PolyPeptide Company Details
11.2.2 PolyPeptide Business Overview
11.2.3 PolyPeptide CMO Peptide Introduction
11.2.4 PolyPeptide Revenue in CMO Peptide Business (2020-2025)
11.2.5 PolyPeptide Recent Development
11.3 USV Peptides
11.3.1 USV Peptides Company Details
11.3.2 USV Peptides Business Overview
11.3.3 USV Peptides CMO Peptide Introduction
11.3.4 USV Peptides Revenue in CMO Peptide Business (2020-2025)
11.3.5 USV Peptides Recent Development
11.4 Thermofischer
11.4.1 Thermofischer Company Details
11.4.2 Thermofischer Business Overview
11.4.3 Thermofischer CMO Peptide Introduction
11.4.4 Thermofischer Revenue in CMO Peptide Business (2020-2025)
11.4.5 Thermofischer Recent Development
11.5 Bio Basic
11.5.1 Bio Basic Company Details
11.5.2 Bio Basic Business Overview
11.5.3 Bio Basic CMO Peptide Introduction
11.5.4 Bio Basic Revenue in CMO Peptide Business (2020-2025)
11.5.5 Bio Basic Recent Development
11.6 JPT
11.6.1 JPT Company Details
11.6.2 JPT Business Overview
11.6.3 JPT CMO Peptide Introduction
11.6.4 JPT Revenue in CMO Peptide Business (2020-2025)
11.6.5 JPT Recent Development
11.7 Genscript
11.7.1 Genscript Company Details
11.7.2 Genscript Business Overview
11.7.3 Genscript CMO Peptide Introduction
11.7.4 Genscript Revenue in CMO Peptide Business (2020-2025)
11.7.5 Genscript Recent Development
11.8 Xinbang Pharma
11.8.1 Xinbang Pharma Company Details
11.8.2 Xinbang Pharma Business Overview
11.8.3 Xinbang Pharma CMO Peptide Introduction
11.8.4 Xinbang Pharma Revenue in CMO Peptide Business (2020-2025)
11.8.5 Xinbang Pharma Recent Development
11.9 ScinoPharm
11.9.1 ScinoPharm Company Details
11.9.2 ScinoPharm Business Overview
11.9.3 ScinoPharm CMO Peptide Introduction
11.9.4 ScinoPharm Revenue in CMO Peptide Business (2020-2025)
11.9.5 ScinoPharm Recent Development
11.10 AmbioPharm
11.10.1 AmbioPharm Company Details
11.10.2 AmbioPharm Business Overview
11.10.3 AmbioPharm CMO Peptide Introduction
11.10.4 AmbioPharm Revenue in CMO Peptide Business (2020-2025)
11.10.5 AmbioPharm Recent Development
11.11 SN Biopharm
11.11.1 SN Biopharm Company Details
11.11.2 SN Biopharm Business Overview
11.11.3 SN Biopharm CMO Peptide Introduction
11.11.4 SN Biopharm Revenue in CMO Peptide Business (2020-2025)
11.11.5 SN Biopharm Recent Development
11.12 CBL
11.12.1 CBL Company Details
11.12.2 CBL Business Overview
11.12.3 CBL CMO Peptide Introduction
11.12.4 CBL Revenue in CMO Peptide Business (2020-2025)
11.12.5 CBL Recent Development
11.13 Piramal Pharma
11.13.1 Piramal Pharma Company Details
11.13.2 Piramal Pharma Business Overview
11.13.3 Piramal Pharma CMO Peptide Introduction
11.13.4 Piramal Pharma Revenue in CMO Peptide Business (2020-2025)
11.13.5 Piramal Pharma Recent Development
11.14 CordenPharma
11.14.1 CordenPharma Company Details
11.14.2 CordenPharma Business Overview
11.14.3 CordenPharma CMO Peptide Introduction
11.14.4 CordenPharma Revenue in CMO Peptide Business (2020-2025)
11.14.5 CordenPharma Recent Development
11.15 CPC Scientific
11.15.1 CPC Scientific Company Details
11.15.2 CPC Scientific Business Overview
11.15.3 CPC Scientific CMO Peptide Introduction
11.15.4 CPC Scientific Revenue in CMO Peptide Business (2020-2025)
11.15.5 CPC Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Bachem
PolyPeptide
USV Peptides
Thermofischer
Bio Basic
JPT
Genscript
Xinbang Pharma
ScinoPharm
AmbioPharm
SN Biopharm
CBL
Piramal Pharma
CordenPharma
CPC Scientific

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂